CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia
Clinical trial NCT06027957 · COMPLETED
Trial details
- NCT number
- NCT06027957
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-02
- Primary completion
- 2025-06-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.